A new approach to control condylar growth by regulating angiogenesis

Archives of Oral Biology

Volumn 52, Issue 11, 2007, Pages 1009-1017

  Li, Q F ^a   Rabie, A B M ^a  

^a Faculty of Dentistry   (Hong Kong)

Author keywords

Angiogenesis; Angiostatin; Condylar growth; Craniofacial growth deformities; Endostatin; FGF; rAAV; Stem cells; VEGF

Indexed keywords

ANGIOGENESIS INHIBITOR; SIGNAL PEPTIDE;

ADENO ASSOCIATED VIRUS; ANGIOGENESIS; ANIMAL; CARTILAGE; CONGENITAL MALFORMATION; GENE THERAPY; GENE VECTOR; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MANDIBLE CONDYLE; METHODOLOGY; NANOTECHNOLOGY; REVIEW; STEM CELL TRANSPLANTATION; VASCULARIZATION;

ANGIOGENESIS INHIBITORS; ANIMALS; CARTILAGE; DEPENDOVIRUS; GENE THERAPY; GENETIC VECTORS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MANDIBULAR CONDYLE; NANOTECHNOLOGY; NEOVASCULARIZATION, PHYSIOLOGIC; STEM CELL TRANSPLANTATION;

EID: 34848847811     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2007.05.009     Document Type: Review

References (112)

1. Bilkay U., Tokat C., Ozek C., Gundogan H., Erdem O., Gurler T., et al. Proteus syndrome. Scand J Plast Reconstr Surg Hand Surg/Nordisk plastikkirurgisk forening [and] Nordisk klubb for handkirurgi 37 5 (2003) 307-310
2. Rabie A.B., She T.T., and Hagg U. Functional appliance therapy accelerates and enhances condylar growth. Am J Orthod Dentofac Orthop 123 1 (2003) 40-48
3. Akiyama H., Chaboissier M.C., Martin J.F., Schedl A., and de Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16 21 (2002) 2813-2828
4. Akiyama H., Lyons J.P., Mori-Akiyama Y., Yang X., Zhang R., Zhang Z., et al. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev 18 9 (2004) 1072-1087
5. Bi W., Huang W., Whitworth D.J., Deng J.M., Zhang Z., Behringer R.R., et al. Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci USA 98 12 (2001) 6698-6703
6. Huang W., Chung U.I., Kronenberg H.M., and de Crombrugghe B. The chondrogenic transcription factor Sox9 is a target of signaling by the parathyroid hormone-related peptide in the growth plate of endochondral bones. Proc Natl Acad Sci USA 98 1 (2001) 160-165
7. Ducy P., and Karsenty G. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 15 4 (1995) 1858-1869
8. Ducy P., Zhang R., Geoffroy V., Ridall A.L., and Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 89 5 (1997) 747-754
9. Gao Y.H., Shinki T., Yuasa T., Kataoka-Enomoto H., Komori T., Suda T., et al. Potential role of cbfa1, an essential transcriptional factor for osteoblast differentiation, in osteoclastogenesis: regulation of mRNA expression of osteoclast differentiation factor (ODF). Biochem Biophys Res Commun 252 3 (1998) 697-702
10. Rabie A.B., Tang G.H., and Hagg U. Cbfa1 couples chondrocytes maturation and endochondral ossification in rat mandibular condylar cartilage. Arch Oral Biol 49 2 (2004) 109-118
11. Kim I.S., Otto F., Zabel B., and Mundlos S. Regulation of chondrocyte differentiation by Cbfa1. Mech Dev 80 2 (1999) 159-170
12. Ng T.C., Chiu K.W., Rabie A.B., and Hagg U. Repeated mechanical loading enhances the expression of Indian hedgehog in condylar cartilage. Front Biosci 11 (2006) 943-948
13. Tang G.H., Rabie A.B., and Hagg U. Indian hedgehog: a mechanotransduction mediator in condylar cartilage. J Dent Res 83 5 (2004) 434-438
14. Kronenberg H.M. Developmental regulation of the growth plate. Nature 423 6937 (2003) 332-336
15. Karaplis A.C., Luz A., Glowacki J., Bronson R.T., Tybulewicz V.L., Kronenberg H.M., et al. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8 3 (1994) 277-289
16. Rabie A.B., Tang G.H., Xiong H., and Hagg U. PTHrP regulates chondrocyte maturation in condylar cartilage. J Dent Res 82 8 (2003) 627-631
17. Ng A.F., Yang Y.O., Wong R.W., Hagg E.U., and Rabie A.B. Factors regulating condylar cartilage growth under repeated load application. Front Biosci 11 (2006) 949-954
18. Rabie A.B., Dai J., and Xu R. Recombinant AAV-mediated VEGF gene therapy induces mandibular condylar growth. Gene Ther (2007)
19. Dai J., and Rabie A.B. Recombinant adeno-associated virus vector hybrids efficiently target different skeletal cells. Front Biosci 12 (2007) 4280-4287
20. Dai J., and Rabie A.B. Direct AAV-mediated gene delivery to the temporomandibular joint. Front Biosci 12 (2007) 2212-2220
21. Catala A.E., and Johnston Jr. L.E. Interstitial growth of septal cartilage in the young albino rat. J Dent Res 59 8 (1980) 1453-1456
22. Segawa K., and Takiguchi R. Ultrastructural alteration of cartilaginous fibril arrangement in the rat mandibular condyle as revealed by high-resolution scanning electron microscopy. Anat Rec 234 4 (1992) 493-499
23. Livne E., Weiss A., and Silbermann M. Changes in growth patterns in mouse condylar cartilage associated with skeletal maturation and senescence. Growth Dev Aging 54 4 (1990) 183-193
24. Hayes A.J., MacPherson S., Morrison H., Dowthwaite G., and Archer C.W. The development of articular cartilage: evidence for an appositional growth mechanism. Anat Embryol 203 6 (2001) 469-479
25. Delatte M., Von den Hoff J.W., van Rheden R.E., and Kuijpers-Jagtman A.M. Primary and secondary cartilages of the neonatal rat: the femoral head and the mandibular condyle. Eur J Oral Sci 112 2 (2004) 156-162
26. Prasanna Bukka M.D.M., and Karaplis A.C. In: Farach-Carson F. (Ed). Bone formation (2004), Springer-Verlag London Limited, London 2004
27. In: Luder H. (Ed). Postnatal development, aging, and degeneration of the temporomandibular joint in humans, monkeys, and rats (1996), Ann Arbor
28. Rabie A.B., Tsai M.J., Hagg U., Du X., and Chou B.W. The correlation of replicating cells and osteogenesis in the condyle during stepwise advancement. Angle Orthod 73 4 (2003) 457-465
29. Rabie A.B., Wong L., and Hagg U. Correlation of replicating cells and osteogenesis in the glenoid fossa during stepwise advancement. Am J Orthod Dentofac Orthop 123 5 (2003) 521-526
30. Lefebvre V., Huang W., Harley V.R., Goodfellow P.N., and de Crombrugghe B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 17 4 (1997) 2336-2346
31. Ng L.J., Wheatley S., Muscat G.E., Conway-Campbell J., Bowles J., Wright E., et al. SOX9 binds DNA, activates transcription, and coexpresses with type II collagen during chondrogenesis in the mouse. Dev Biol 183 1 (1997) 108-121
32. Rabie A.B., She T.T., and Harley V.R. Forward mandibular positioning up-regulates SOX9 and type II collagen expression in the glenoid fossa. J Dent Res 82 9 (2003) 725-730
33. Suda N., Shibata S., Yamazaki K., Kuroda T., Senior P.V., Beck F., et al. Parathyroid hormone-related protein regulates proliferation of condylar hypertrophic chondrocytes. J Bone Miner Res 14 11 (1999) 1838-1847
34. Hamada T., Suda N., and Kuroda T. Immunohistochemical localization of fibroblast growth factor receptors in the rat mandibular condylar cartilage and tibial cartilage. J Bone Miner Metabol 17 4 (1999) 274-282
35. Zelzer E., Glotzer D.J., Hartmann C., Thomas D., Fukai N., Soker S., et al. Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev 106 1-2 (2001) 97-106
36. Rabie A.B., and Hagg U. Factors regulating mandibular condylar growth. Am J Orthod Dentofac Orthop 122 4 (2002) 401-409
37. Guenther H.L., Fleisch H., and Sorgente N. Endothelial cells in culture synthesize a potent bone cell active mitogen. Endocrinology 119 1 (1986) 193-201
38. Rabie A.B. Vascular endothelial growth pattern during demineralized bone matrix induced osteogenesis. Connect Tissue Res 36 4 (1997) 337-345
39. Rabie A.B., Leung F.Y., Chayanupatkul A., and Hagg U. The correlation between neovascularization and bone formation in the condyle during forward mandibular positioning. Angle Orthod 72 5 (2002) 431-438
40. Blumer M.J., Longato S., Richter E., Perez M.T., Konakci K.Z., and Fritsch H. The role of cartilage canals in endochondral and perichondral bone formation: are there similarities between these two processes?. J Anat 206 4 (2005) 359-372
41. Peng H., Wright V., Usas A., Gearhart B., Shen H.C., Cummins J., et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110 6 (2002) 751-759
42. Peng H., Usas A., Olshanski A., Ho A.M., Gearhart B., Cooper G.M., et al. VEGF improves, whereas sFlt1 inhibits, BMP2-induced bone formation and bone healing through modulation of angiogenesis. J Bone Miner Res 20 11 (2005) 2017-2027
43. Maes C., Stockmans I., Moermans K., Van Looveren R., Smets N., Carmeliet P., et al. Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. J Clin Invest 113 2 (2004) 188-199
44. Harper J., and Klagsbrun M. Cartilage to bone--angiogenesis leads the way. Nat Med 5 6 (1999) 617-618
45. Conway E.M., Collen D., and Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res 49 3 (2001) 507-521
46. Egginton S., Zhou A.L., Brown M.D., and Hudlicka O. The role of pericytes in controlling angiogenesis in vivo. Adv Exp Med Biol 476 (2000) 81-99
47. Benjamin L.E., Golijanin D., Itin A., Pode D., and Keshet E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 103 2 (1999) 159-165
48. Benjamin L.E., Hemo I., and Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development (Cambridge England) 125 9 (1998) 1591-1598
49. Pettersson A., Nagy J.A., Brown L.F., Sundberg C., Morgan E., Jungles S., et al. Heterogeneity of the angiogenic response induced in different normal adult tissues by vascular permeability factor/vascular endothelial growth factor. Lab Invest 80 1 (2000) 99-115
50. Klagsbrun M., and D'Amore P.A. Vascular endothelial growth factor and its receptors. Cytokine Growth Factor Rev 7 3 (1996) 259-270
51. Ferrara N., and Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 18 1 (1997) 4-25
52. Carlevaro M.F., Cermelli S., Cancedda R., and Descalzi Cancedda F. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J Cell Sci 113 Pt 1 (2000) 59-69
53. Deckers M.M., Karperien M., van der Bent C., Yamashita T., Papapoulos S.E., and Lowik C.W. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation. Endocrinology 141 5 (2000) 1667-1674
54. Connolly D.T., Heuvelman D.M., Nelson R., Olander J.V., Eppley B.L., Delfino J.J., et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84 5 (1989) 1470-1478
55. Keck P.J., Hauser S.D., Krivi G., Sanzo K., Warren T., Feder J., et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246 4935 (1989) 1309-1312
56. Ferrara N., Houck K., Jakeman L., and Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13 1 (1992) 18-32
57. Triffitt J.T., Joyner C.J., Oreffo R.O., and Virdi A.S. Osteogenesis: bone development from primitive progenitors. Biochem Soc Trans 26 1 (1998) 21-27
58. Abedi H., and Zachary I. Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells. J Biol Chem 272 24 (1997) 15442-15451
59. Pedram A., Razandi M., and Levin E.R. Extracellular signal-regulated protein kinase/Jun kinase cross-talk underlies vascular endothelial cell growth factor-induced endothelial cell proliferation. J Biol Chem 273 41 (1998) 26722-26728
60. Rousseau S., Houle F., Landry J., and Huot J. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 15 18 (1997) 2169-2177
61. Zelzer E., Mamluk R., Ferrara N., Johnson R.S., Schipani E., and Olsen B.R. VEGFA is necessary for chondrocyte survival during bone development. Development (Cambridge, England) 131 9 (2004) 2161-2171
62. Harris S.E., Bonewald L.F., Harris M.A., Sabatini M., Dallas S., Feng J.Q., et al. Effects of transforming growth factor beta on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 9 6 (1994) 855-863
63. Eppley B.L., Doucet M., Connolly D.T., and Feder J. Enhancement of angiogenesis by bFGF in mandibular bone graft healing in the rabbit. J Oral Maxillofac Surg 46 5 (1988) 391-398
64. Weiss A.P., Olmedo M.L., Lin J.C., and Ballock R.T. Growth factor modulation of the formation of a molded vascularized bone graft in vivo. J Hand Surg [Am] 20 1 (1995) 94-100
65. Ornitz D.M., and Marie P.J. FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev 16 12 (2002) 1446-1465
66. Lindahl P., Karlsson L., Hellstrom M., Gebre-Medhin S., Willetts K., Heath J.K., et al. Alveogenesis failure in PDGF-A-deficient mice is coupled to lack of distal spreading of alveolar smooth muscle cell progenitors during lung development. Development (Cambridge, England) 124 20 (1997) 3943-3953
67. Shyu K.G., Manor O., Magner M., Yancopoulos G.D., and Isner J.M. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation 98 19 (1998) 2081-2087
68. Luttun A., Tjwa M., Moons L., Wu Y., Angelillo-Scherrer A., Liao F., et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 8 8 (2002) 831-840
69. Rissanen T.T., Markkanen J.E., Arve K., Rutanen J., Kettunen M.I., Vajanto I., et al. Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model. FASEB J 17 1 (2003) 100-102
70. O'Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M., et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79 2 (1994) 315-328
71. Cao Y. Antiangiogenic cancer therapy. Semin Cancer Biol 14 2 (2004) 139-145
72. Frank P., Braunshofer-Reiter C., Wintersberger U., Grimm R., and Busen W. Cloning of the cDNA encoding the large subunit of human RNase HI, a homologue of the prokaryotic RNase HII. Proc Natl Acad Sci USA 95 22 (1998) 12872-12877
73. Kanner S.B., Reynolds A.B., Vines R.R., and Parsons J.T. Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases. Proc Natl Acad Sci USA 87 9 (1990) 3328-3332
74. Sharon M., Oren Z., Shai Y., and Anglister J. 2D-NMR and ATR-FTIR study of the structure of a cell-selective diastereomer of melittin and its orientation in phospholipids. Biochemistry 38 46 (1999) 15305-15316
75. Koshida R., Ou J., Matsunaga T., Chilian W.M., Oldham K.T., Ackerman A.W., et al. Angiostatin: a negative regulator of endothelial-dependent vasodilation. Circulation 107 6 (2003) 803-806
76. Shweiki D., Itin A., Soffer D., and Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359 6398 (1992) 843-845
77. Levy A.P., Levy N.S., Wegner S., and Goldberg M.A. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 270 22 (1995) 13333-13340
78. Oh S.P., Warman M.L., Seldin M.F., Cheng S.D., Knoll J.H., Timmons S., et al. Cloning of cDNA and genomic DNA encoding human type XVIII collagen and localization of the alpha 1(XVIII) collagen gene to mouse chromosome 10 and human chromosome 21. Genomics 19 3 (1994) 494-499
79. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88 2 (1997) 277-285
80. Abdollahi A., Hahnfeldt P., Maercker C., Grone H.J., Debus J., Ansorge W., et al. Endostatin's antiangiogenic signaling network. Mol Cell 13 5 (2004) 649-663
81. Gupta K., Gupta P., Wild R., Ramakrishnan S., and Hebbel R.P. Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis. Angiogenesis 3 2 (1999) 147-158
82. Guo N., Krutzsch H.C., Inman J.K., and Roberts D.D. Thrombospondin 1 and type I repeat peptides of thrombospondin 1 specifically induce apoptosis of endothelial cells. Cancer Res 57 9 (1997) 1735-1742
83. Griffith E.C., Su Z., Niwayama S., Ramsay C.A., Chang Y.H., and Liu J.O. Molecular recognition of angiogenesis inhibitors fumagillin and ovalicin by methionine aminopeptidase 2. Proc Natl Acad Sci USA 95 26 (1998) 15183-15188
84. Ingber D., Fujita T., Kishimoto S., Sudo K., Kanamaru T., Brem H., et al. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348 6301 (1990) 555-557
85. Brem H., Gresser I., Grosfeld J., and Folkman J. The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis. J Pediatr Surg 28 10 (1993) 1253-1257
86. Kusaka M., Sudo K., Fujita T., Marui S., Itoh F., Ingber D., et al. Potent anti-angiogenic action of AGM-1470: comparison to the fumagillin parent. Biochem Biophys Res Commun 174 3 (1991) 1070-1076
87. Parangi S., O'Reilly M., Christofori G., Holmgren L., Grosfeld J., Folkman J., et al. Antiangiogenic therapy of transgenic mice impairs de novo tumor growth. Proc Natl Acad Sci USA 93 5 (1996) 2002-2007
88. Bergers G., Javaherian K., Lo K.M., Folkman J., and Hanahan D. Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science 284 5415 (1999) 808-812
89. Zhang W., Ran S., Sambade M., Huang X., and Thorpe P.E. A monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR/Flk-1) inhibits vascular expression of Flk-1 and tumor growth in an orthotopic human breast cancer model. Angiogenesis 5 1-2 (2002) 35-44
90. Dupont J., Bienvenu B., Aghajanian C., Pezzulli S., Sabbatini P., Vongphrachanh P., et al. Phase I and pharmacokinetic study of the novel oral cell-cycle inhibitor Ro 31-7453 in patients with advanced solid tumors. J Clin Oncol 22 16 (2004) 3366-3374
91. Stadler W.M., Cao D., Vogelzang N.J., Ryan C.W., Hoving K., Wright R., et al. A randomized Phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancer. Clin Cancer Res 10 10 (2004) 3365-3370
92. Stopeck A., Sheldon M., Vahedian M., Cropp G., Gosalia R., and Hannah A. Results of a Phase I dose-escalating study of the antiangiogenic agent, SU5416, in patients with advanced malignancies. Clin Cancer Res 8 9 (2002) 2798-2805
93. Leung F.Y., Rabie A.B., and Hagg U. Neovascularization and bone formation in the condyle during stepwise mandibular advancement. Eur J Orthod 26 2 (2004) 137-141
94. Fortina P., Kricka L.J., Surrey S., and Grodzinski P. Nanobiotechnology: the promise and reality of new approaches to molecular recognition. Trends Biotechnol 23 4 (2005) 168-173
95. Whitesides G.M. The 'right' size in nanobiotechnology. Nat Biotechnol 21 10 (2003) 1161-1165
96. Niemeyer CMaM C.A. Nanobiotechnology: concepts applications and perspectives (2004), Wiley
97. Park J.W. Liposome-based drug delivery in breast cancer treatment. Breast Cancer Res 4 3 (2002) 95-99
98. Chang T.M. Bioencapsulated hepatocytes for experimental liver support. J Hepatol 34 1 (2001) 148-149
99. Read T.A., Sorensen D.R., Mahesparan R., Enger P.O., Timpl R., Olsen B.R., et al. Local endostatin treatment of gliomas administered by microencapsulated producer cells. Nat Biotechnol 19 1 (2001) 29-34
100. de Vos P., Smedema I., van Goor H., Moes H., van Zanten J., Netters S., et al. Association between macrophage activation and function of micro-encapsulated rat islets. Diabetologia 46 5 (2003) 666-673
101. Wong H., and Chang T.M. The microencapsulation of cells within alginate poly-L-lysine microcapsules prepared with the standard single step drop technique: histologically identified membrane imperfections and the associated graft rejection. Biomater Artif Cells Immobiliz Biotechnol 19 4 (1991) 675-686
102. Alison M.R., Poulsom R., Jeffery R., Dhillon A.P., Quaglia A., Jacob J., et al. Hepatocytes from non-hepatic adult stem cells. Nature 406 6793 (2000) 257
103. McNeish J. Embryonic stem cells in drug discovery. Nat Rev Drug Discov 3 1 (2004) 70-80
104. Dai J., and Rabie A.B. The use of recombinant adeno-associated virus for skeletal gene therapy. Orthod Craniofac Res 10 1 (2007) 1-14
105. Bonadio J., and Cunningham M.L. Genetic approaches to craniofacial tissue repair. Ann NY Acad Sci 961 (2002) 48-57
106. Buller R.M., Janik J.E., Sebring E.D., and Rose J.A. Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication. J Virol 40 1 (1981) 241-247
107. Berns K.I. Parvovirus replication. Microbiol Rev 54 3 (1990) 316-329
108. Xiao X., Li J., and Samulski R.J. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J Virol 70 11 (1996) 8098-8108
109. Monahan P.E., and Samulski R.J. Adeno-associated virus vectors for gene therapy: more pros than cons?. Mol Med Today 6 11 (2000) 433-440
110. Lewis P.F., and Emerman M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. J Virol 68 1 (1994) 510-516
111. Manilla P., Rebello T., Afable C., Lu X., Slepushkin V., Humeau L.M., et al. Regulatory considerations for novel gene therapy products: a review of the process leading to the first clinical lentiviral vector. Hum Gene Ther 16 1 (2005) 17-25
112. Rabie A.B., Wong L., and Tsai M. Replicating mesenchymal cells in the condyle and the glenoid fossa during mandibular forward positioning. Am J Orthod Dentofac Orthop 123 1 (2003) 49-57